docetaxel anhydrous has been researched along with Inappropriate ADH Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, F; Stewart, J; Turner, N; White, S | 1 |
| Fujimoto, K; Koizumi, T; Komatsu, Y; Kubo, K; Saegusa, T; Urushihata, K; Yasuo, M | 1 |
| Heilmann, M; Langer-Nitsche, C; Lück, HJ | 1 |
3 other study(ies) available for docetaxel anhydrous and Inappropriate ADH Syndrome
| Article | Year |
|---|---|
Syndrome of inappropriate anti-diuretic hormone secretion secondary to carboplatin after docetaxel-carboplatin-trastuzumab combination for early stage HER-2 positive breast cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Docetaxel; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Middle Aged; Receptor, ErbB-2; Taxoids; Trastuzumab | 2012 |
[A case of hyponatremia associated with combination therapy of systemic chemotherapy and paroxetine].
Topics: Aged; Antidepressive Agents, Second-Generation; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Paroxetine; Selective Serotonin Reuptake Inhibitors; Taxoids | 2006 |
Severe syndrome of inappropriate antidiuretic hormone secretion with docetaxel treatment in metastatic breast cancer.
Topics: Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Humans; Inappropriate ADH Syndrome; Paclitaxel; Taxoids | 2000 |